People · Operator

Matt Milanowski

Named in public records as an officer, director or promoter · active 2019–2022 · Other Health Care, Biotechnology

2
Companies
4
Filings
$9.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
HAPPE Spine, LLCOther Health CareSeries A$8.4M$10.0M2019
Genesis New Ventures, LLCBiotechnologyPre-Seed$650K$1.7M2022
Operator network

Matt Milanowski at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Steven Foster · 3 companies · 1 sharedSteven FosterAndrew Lott · 1 companies · 1 sharedAndrew LottBen Olds · 1 companies · 1 sharedBen OldsBrian McCollum · 1 companies · 1 sharedBrian McCollumDoug Snell · 1 companies · 1 sharedDoug SnellMatt Ahearn · 1 companies · 1 sharedMatt AhearnRyan Roeder · 1 companies · 1 sharedRyan RoederTodd Smullen · 1 companies · 1 sharedTodd SmullenGreg Downey · 7 companies · 1 sharedGreg DowneyDonald Running · 5 companies · 1 sharedDonald RunningDaniel F Justin · 2 companies · 1 sharedDaniel F JustinConnor Sullivan · 1 companies · 1 sharedConnor SullivanDan Justin · 1 companies · 1 sharedDan JustinJustin F Kaler · 1 companies · 1 sharedJustin F KalerHAPPE Spine, LLC · $8.4M raisedHAPPE Spine, LLCGenesis New Ventures, LLC · $0.7M raisedGenesis New Ventures,…Matt MilanowskiMM
Matt Milanowski Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Matt Milanowski on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Greg Downey17
Donald Running15
Steven Foster13
Daniel F Justin12
Todd Smullen11
Andrew Lott11
Doug Snell11
Ben Olds11
Justin F Kaler11
Connor Sullivan11
Dan Justin11
Matt Ahearn11
Brian McCollum11
Ryan Roeder11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.